Roche unveils Tamiflu program for U.S. firms

06/27/2008 | USA Today · Wall Street Journal, The

Roche Holding AG has launched a program that guarantees supplies of its influenza drug Tamiflu to U.S. companies in the event of a flu pandemic. The program, which requires a minimum order of 2,500 courses of the drug at $6 each, is part of the Swiss drugmaker's strategy to recover from slumping sales of the treatment.

View Full Article in:

USA Today · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY